Global Lifestyle Archives | Page 108 of 462 | Be Korea-savvy

Archive by category Global Lifestyle

Sandoz Announces Agreement to Acquire CIMERLI® Business from Coherus, Strengthening Position in US Market

Sandoz Announces Agreement to Acquire CIMERLI® Business from Coherus, Strengthening Position in US Market

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®** (ranibizumab-injection) for all approved indications Acquisition strengthens Sandoz ophthalmology portfolio Basel, January 22, 2024 (Korea Bizwire) – Sandoz, the global leader in generic and biosimilar medicines, has signed an agreement to acquire the US [...]

The Sea Index and Yacht Club de Monaco’s Leadership in Eco-responsibility for Yachts

The Sea Index and Yacht Club de Monaco’s Leadership in Eco-responsibility for Yachts

MONACO, Jan. 18, 2024 (Korea Bizwire) – A carbon footprint calculator for superyachts targeting the environmental objective to mitigate CO2 emissions in yachting. It is the Sea Index, a tool created in 2020 by the Yacht Club de Monaco to accelerate the diffusion of more sustainability in this sector. Basically, it evaluates the energy intensity [...]

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

SHANGHAI, China, Jan. 17, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced the publication of results from the prespecified interim analysis for event-free survival (EFS) in patients with stage III non-Small Cell [...]

Nyxoah Announces 2024 Strategic Priorities

Nyxoah Announces 2024 Strategic Priorities

Mont-Saint-Guibert, Belgium, Jan. 17 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced, in anticipation of upcoming investor meetings, its strategic priorities for 2024.             2024 Strategic Priorities Complete patient follow [...]

Single Use Support Continues to Grow, Expanding Its Team by 40%

Single Use Support Continues to Grow, Expanding Its Team by 40%

Innovative process solution provider Single Use Support continues to deliver strong organic growth, supported by an expansion in its employee base. With a successful year 2023 in the rear-view mirror, 2024 is already shaping up to be even better. KUFSTEIN, Austria, Jan. 16, 2024 (Korea Bizwire) – Single Use Support has established the groundwork for [...]

Sportradar Launches FanID Connecting Rightsholders and Brands with Sports Fans in a Post-Cookie World

Sportradar Launches FanID Connecting Rightsholders and Brands with Sports Fans in a Post-Cookie World

Sportradar FanID features first data clean room for sports industry, delivers personalized marketing at scale ST. GALLEN, Switzerland, Jan. 16, 2024 (Korea Bizwire) – Sportradar (NASDAQ: SRAD) today announced the launch of Sportradar FanID, a unique, end-to-end first-party marketing solution combining the first data clean room for the sports industry with the company’s proprietary marketing [...]

Boehringer Expands Production Site in Greece for New Medicine

Boehringer Expands Production Site in Greece for New Medicine

Ingelheim am Rhein, Germany, Jan. 11 (Korea Bizwire) –  Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the company will increase the manufacturing capacity of new and existing medications. Main disease areas include cardio-renal-metabolic (CRM) diseases, [...]

New Study Confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant Reduces Full-thickness Rotator Cuff Re-tear Rates¹ by 68%

New Study Confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant Reduces Full-thickness Rotator Cuff Re-tear Rates¹ by 68%

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears                Hull, UK, Jan 11 (Korea Bizwire) – Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently completed randomized controlled trial (RCT). Published online [...]